Pages • 2
Gilead Science: Access Program Essay Preview: Gilead Science: Access Program Report this essay Gilead Science: Access Program In 2008, Gileads top three HIV treatments generated 84% of its product sales. ( Sales report?): high sales contributions/key disease area to sustain growth 8 of 10 new patients diagnosed with HIV in the US start on Gilead.